Evidence map›Paper›PMID 22895728›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2012

Elimination of GRK2 from cholinergic neurons reduces behavioral sensitivity to muscarinic receptor activation.

Tanya L Daigle, Marc G Caron

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Selective deletion of GRK2 alters psychostimulant-induced behaviors and dopamine neurotransmission.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2014
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Tanya L DaigleDepartment of Cell Biology, Duke University Medical Center, Durham, North Carolina 27710, USA. t.daigle@cellbio.duke.edu
Marc G Caron
Duke University · USDuke University Hospital · US

Funding

Akt/GSK-3 Signaling Cascade and the Actions of DopamineR37MH073853 · NIMH · DUKE UNIVERSITY · PI CARON, MARC G. · 2011 to 2020
$6.4M
Akt/GSK-3 Signaling Cascade and the Actions of DopamineR01MH073853 · NIMH · DUKE UNIVERSITY · PI CARON, MARC G. · 2005 to 2009
$2.1M
Role of beta-arrestin-2 signaling complexes in the actions of psychostimulantsF32DA030026 · NIDA · DUKE UNIVERSITY · PI DAIGLE, TANYA LYNN · 2010 to 2012
$159k
NIDA NIH HHS DA030026NIDA NIH HHS F32 DA030026NIMH NIH HHS MH073853NIMH NIH HHS R01 MH073853NIMH NIH HHS R37 MH073853
6 · The paper itself

Abstract

Although G-protein-coupled receptor kinase 2 (GRK2) is the most widely studied member of a family of kinases that has been shown to exert powerful influences on a variety of G-protein-coupled receptors, its role in the brain remains largely unknown. Here we report the localization of GRK2 in the mouse brain and generate novel conditional knock-out (KO) mice to assess the physiological importance of this kinase in cholinergic neurons. Mice with the selective deletion of GRK2 in this cell population (ChAT(IRES-cre)Grk2(f/f) KO mice) exhibit reduced behavioral responsiveness to challenge with oxotremorine-M (Oxo-M), a nonselective muscarinic acetylcholine receptor agonist. Specifically, Oxo-M-induced hypothermia, hypolocomotion, and salivation were markedly reduced in these animals, while analgesic responses were unaltered. In contrast, we found that GRK2 deficiency in cholinergic neurons does not alter cocaine-induced psychomotor activation, behavioral sensitization, or conditioned place preference. These results demonstrate that the elimination of GRK2 in cholinergic neurons reduces sensitivity to select muscarinic-mediated behaviors, while dopaminergic effects remain intact and further suggests that GRK2 may selectively impair muscarinic acetylcholine receptor-mediated function in vivo.

Indexed as

Analysis of VarianceAnimalsBody TemperatureBrainCholine O-AcetyltransferaseCholinergic NeuronsCocaineConditioning, OperantDopamine Uptake InhibitorsG-Protein-Coupled Receptor Kinase 2HyperalgesiaMiceMice, Inbred C57BLMice, TransgenicMotor ActivityMuscarinic AgonistsCholine O-AcetyltransferaseCocaineDopamine Uptake InhibitorsG-Protein-Coupled Receptor Kinase 2GRK2 protein, mouseMuscarinic AgonistsOxotremorineoxotremorine MReceptors, Muscarinic

Identifiers

PMID22895728
PMCPMC3428034
OpenAlexW2010696362

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.